The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
D000328:Adult; D000368:Aged; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D003315:Cornea / Q000187:drug effects; D003316:Corneal Diseases / Q000188:drug therapy*; D016039:Corneal Transplantation; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004311:Double-Blind Method; D004487:Edema / Q000188:drug therapy*; D005131:Eye Injuries / Q000150:complications; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005642:Fuchs' Endothelial Dystrophy / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D006988:Hyphema / Q000188:drug therapy* / Q000209:etiology; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid